deltatrials
Recruiting OBSERVATIONAL NCT05284877

The Organ Transplant Recipient HPV and Skin Cancer Study

Sponsor: Danish Cancer Society

Interventions No intervention
Updated 6 times since 2022 Last updated: Mar 27, 2025 Started: Mar 10, 2022 Primary completion: Mar 31, 2028 Completion: Mar 31, 2043
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05284877, this observational or N/A phase trial focuses on Cervical Cancer and Cervical Intraepithelial Neoplasia and remains actively recruiting participants. Sponsored by Danish Cancer Society, it has been updated 6 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Apr 2022 – ~May 2022 · 30 days · monthly snapshotRecruiting~May 2022 – ~Apr 2023 · 11 months · monthly snapshotRecruiting~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~May 2025 · 8 months · monthly snapshotRecruiting~May 2025 – present · 14 months · monthly snapshotRecruiting

Change History

6 versions recorded
  1. May 2025 — Present [monthly]

    Recruiting

  2. Sep 2024 — May 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Apr 2023 — Jul 2024 [monthly]

    Recruiting

  5. May 2022 — Apr 2023 [monthly]

    Recruiting

Show 1 earlier version
  1. Apr 2022 — May 2022 [monthly]

    Recruiting

    First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Danish Cancer Society
  • Herlev and Gentofte Hospital
  • Merete Haedersdal
  • Rigshospitalet, Denmark
  • Vejle Hospital
  • Zealand University Hospital
Data source: Bispebjerg Hospital

For direct contact, visit the study record on ClinicalTrials.gov .